JUN 15, 2016 7:30 AM PDT

Glycomics and glycoproteomics by CESI-MS for biomarker discovery and biopharmaceutical characterization

Sponsored by: Sciex, Sciex
Speaker
  • PhD Candidate, Center for Proteomics and Metabolomics, Leiden University Medical Center
    Biography
      Guinevere S. M. Kammeijer received a BSc degree in Biotechnology - Forensic Sciences from University of Applied Science van Hall Larenstein, Leeuwarden followed by a MSc in Analytical Chemistry at the VU University, Amsterdam. The MSc included an internship at the Center for Proteomics and Metabolomics at Leiden University Medical Center where she focused on small scale sample preparation with CESI-MS/MS.

      Currently, she is a PhD candidate at the same Center for Proteomics and Metabolomics under the supervision of Prof. Manfred Wuhrer. Her project involves exploring CESI-MS/MS for protein glycosylation analysis with a focus on the analysis of glyco-peptides, employing a porous nano-sprayer for MS coupling.

    Abstract
    Glycosylation is one of the most prevalent co- and post-translational modifications of human proteins and is known to affect the protein properties. Glycosylation is known to be involved in many different diseases. The sialic acids at the end of the glycan chain serve as a binding site for toxins, pathogens and human lectins in a linkage-specific manner having great biomarker potential. During the development and production of biopharmaceuticals glycosylation is a critical quality attribute and therefore has to be monitored. It is known that different cell culture conditions can lead to different glycoform patterns of specific proteins. Characterization of the heterogeneous character of glycoproteins in biopharmaceuticals and in biomarker discovery can be challenging and mass spectrometry (MS) based platforms are increasingly being used for the glycosylation analysis.

    In this webinar we investigate the use of CESI-MS, which is capillary electrophoresis (CE) separation combined with sheathless electrospray ionization (ESI) for biomarker discovery targeting the glycoprotein prostate specific antigen (PSA). Furthermore, in combination with a dopant enriched nitrogen gas (DEN-gas) the analysis of tryptic Fc-N-glycopeptides of a monoclonal IgG1 antibody (mAb) are explored. The precision of CESI-MS in glycosylation profiling will be compared to nano liquid chromatography (LC)–ESI–MS and matrix assisted laser desorption/ionization (MALDI)–TOF–MS. The improved repeatability and sensitivity by employing the DEN-gas will be discussed as well its application for the analysis of other glycoproteins. Moreover, CESI-MS with DEN-gas will be reviewed for the analysis of glycans after reducing-end labeling.

    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    APR 27, 2020 9:00 AM PDT
    C.E. CREDITS
    APR 27, 2020 9:00 AM PDT
    DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 04, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 04, 2020 9:00 AM PDT
    DATE: May 4, 2020 TIME: 9:00am PT, 12:00pm ET...
    MAR 27, 2020 11:00 AM PDT
    C.E. CREDITS
    MAR 27, 2020 11:00 AM PDT
    DATE: March 27, 2020 TIME: 11:00am PT, 2:00pm ET Adeno-associated virus (AAV) is one of the most commonly used delivery vehicles in gene therapy development. However, the presence of product...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    Loading Comments...
    Show Resources
    Attendees
    • See more